Determining the value contribution of selexipag for the...

Determining the value contribution of selexipag for the treatment of pulmonary arterial hypertension (PAH) in Spain using reflective multi-criteria decision analysis (MCDA)

Jiménez, Alberto, Ais, Arantza, Beaudet, Amélie, Gil, Alicia
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Orphanet Journal of Rare Diseases
DOI:
10.1186/s13023-018-0966-4
Date:
December, 2018
File:
PDF, 1.05 MB
english, 2018
Conversion to is in progress
Conversion to is failed